CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the safety and preliminary efficacy of olaparib and vorinostat when used together in participants with relapsed/refractory and or metastatic breast...
Phase 1
Houston, Texas, United States
This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...
Phase 2
Houston, Texas, United States and 10 other locations
This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...
Phase 2
Houston, Texas, United States and 6 other locations
works in treating HER2-negative (HER2-low or HER2-0) metastatic breast cancer.The names of the study drugs involved in this study a...
Phase 2
Houston, Texas, United States and 10 other locations
triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...
Phase 2
Houston, Texas, United States and 9 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Houston, Texas, United States and 31 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Houston, Texas, United States and 9 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Webster, Texas, United States and 78 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Houston, Texas, United States and 32 other locations
This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...
Phase 2
Houston, Texas, United States and 16 other locations
Clinical trials
Research sites
Resources
Legal